Happy Thanksgiving from Susan

  Wishing everyone a very Happy Thanksgiving! I love this holiday! Always filled with family, good stories, good food and very good times. I...

Thursday, October 17, 2019


Exercise Advice for Surviving Cancer, and Maybe Avoiding It

New guidelines say exercise may help cancer patients live longer, or help you avoid getting cancer in the first place.
Image
CreditCreditKendrick Brinson for The New York Times
Even a little exercise may help people avoid and survive many types of cancer, according to new exercise guidelines released today that focus on how exercise affects cancer outcomes.
The guidelines, issued jointly by the American College of Sports Medicine, the American Cancer Society and 15 other international organizations, update almost decade-old recommendations with new science and specific advice about how much and what types of exercise may be the most needed, helpful and tolerable for anyone facing a cancer diagnosis.
Cancer is, of course, one of the world’s most common major diseases, with more than 18 million people globally diagnosed with some form of the condition in 2018. It also is often treatable and today, millions of people are cancer survivors.
But there are high fiscal and physical costs related to cancer. Treatments, while frequently effective, can leave people feeling ill, anxious, exhausted and frail, and may cause collateral damage to the heart or other parts of the body.
So, physicians, therapists and scientists, working with cancer patients, continue to look for accessible, inexpensive ways to improve the lives of cancer patients and also, more fundamentally, reduce the risk that someone will develop cancer in the first place.
Exercise was an obvious candidate. Whether aerobic or resistance, exercise is known to build strength, fight fatigue and lift gloom. But many researchers, clinicians, patients and their families have worried that it might be unsafe for people with cancer; that it might, somehow, make people’s condition worse.
In 2008, a large group of researchers convened to comb through the available science about exercise and cancer and decide if there was enough evidence to tell patients that they could and even should work out. In 2010, the group published its recommendations, which amounted to saying that exercise appeared to be safe for most people with cancer and they should try, in general, to be active.
Since then, however, there has been “exponential growth” in research related to exercise and cancer, says Kathryn Schmitz, a professor of public health and cancer control at Penn State University and the immediate past president of the American College of Sports Medicine.
So, last year, she and almost 40 other researchers from 17 international health groups gathered to determine whether there was sufficient evidence now to refine the recommendations about cancer and exercise. The group wound up gathering hundreds of studies involving animals and people that examined the impacts of exercise on dozens of aspects of cancer risk and cancer recovery.
And they concluded that there was more than enough evidence to start suggesting that exercise should be a part of standard treatment for most people with cancer. They also found that exercise should be considered a means to substantially drop the risk of developing cancer in the first place.
Specifically, the scientists, in separate reviews being published today in Medicine & Science in Sports & Exercise and CA: A Cancer Journal for Clinicians, report that physically active people have as much as 69 percent less risk of being diagnosed with certain cancers than sedentary people. Exercise seems to be especially potent at lessening the likelihood of developing seven common malignancies, the new recommendations add: colon, breast, endometrial, kidney, bladder, esophageal and stomach cancers.
The recommendations also point out that, in multiple recent studies, exercise changed the trajectory of cancer once it began. In animal experiments cited in the new reviews, exercise altered the molecular environment around some tumors, stalling or even halting their growth. And in people, exercising during and after cancer treatment was associated with longer subsequent life spans, the reviews found.
Exercise also seems to lessen cancer patients’ feelings of anxiety or depression and their sometimes debilitating fatigue, the new recommendations report.
And while there had been some concern that exercise might increase the risks for or severity of upper-body lymphedema, the swelling and fluid retention that is common among women recovering from breast cancer, exercise was not associated with an increased risk
Based on these findings, the authors of the new recommendations conclude that people with cancer should aim to exercise at least three times per week at a moderate intensity, such as by brisk walking, for at least 30 minutes, and also try to lift weights twice a week, if possible.
These recommendations are a bit lighter than the standard, governmental guidelines for the general public, which call for moderate aerobic exercise five times per week, plus several sessions of weight training.
Dr. Schmitz says the available science indicates that working out three times a week is the most likely to be feasible and safe for almost everyone with cancer. “The evidence is clear that going from nothing” — from being totally sedentary — “to something is helpful” for people completing or recovering from cancer treatment, she says. Check with your doctor before starting an exercise regimen, but for those who are able to, she adds, “more is better.”
She and her colleagues hope that future studies will help to pin down more precise, granular doses of exercise that doctors can prescribe to aid in cancer treatment and prevention in general and against specific types of cancer in particular. They also hope to determine whether or not there is any upper limit on the amount of healthy exercise for people with cancer.
But for now, Dr. Schmitz says, the primary recommendation she and her colleagues would offer to anyone dealing with or hoping to avoid cancer is: “Get up. Move. It’s so simple and so essential. Get up and move.”

Tuesday, October 15, 2019




No Painkillers, No Pain

dental exam using pink light.
Preventing one of the worst side effects of cancer treatment, without drugs.
There is now a dramatically improved line of defense against oral mucositis, a common and often debilitating side effect of cancer treatment.
It’s light.
People undergoing radiation and other forms of cancer treatment are at high risk of developing oral mucositis, or extremely painful ulcers in the mouth. According to new worldwide guidelines co-authored by a University at Buffalo researcher, a form of low-dose light treatment—called photobiomodulation therapy—can now be considered a go-to remedy for many of those patients. This therapy can effectively prevent one of the worst aspects of treating cancer, not only improving quality of life during treatment but also potentially improving outcomes by encouraging completion of treatment regimens.

An all-too-common problem

The mouth sores associated with oral mucositis can make talking and eating difficult, derail treatment, and even result in hospitalization and a feeding tube. And the condition is prevalent, affecting close to 40% of patients on chemotherapy, nearly 70% of those getting stem cell transplants and almost 80% of those receiving radiation therapy.
Opioid painkillers are frequently prescribed to counter the pain, but those come with their own problematic side effects, including the potential for addiction.

A safer solution

Light therapies have existed for decades. At a high power, often in the form of a laser, light is used to cut or destroy tissue. But at a low level, it has the ability to relieve pain and promote healing.
“I have increasingly appreciated the role of light as a fundamental element for health,” says Praveen Arany, assistant professor of oral biology and biomedical engineering at UB and president of the World Association for photobiomoduLation Therapy (WALT). Arany’s research focuses on the molecular mechanisms of low-dose light therapy, as well as making it more affordable and effective. He is currently testing a device that would allow people to self-administer the therapy at home.
Arany is among 16 global experts who issued the new guidelines. Among other findings, they identified five new protocols, recommending light therapy for stem cell transplant patients and head and neck cancer patients receiving radiation therapy. No major short-term side effects were reported.
“This is a major milestone for the field,” Arany says. “We are confident these guidelines will provide a clear path for several exciting clinical applications, ranging from Alzheimer’s disease and Parkinson’s disease to depression, age-related macular degeneration, arthritis, hair loss, wound healing and more.”

http://www.buffalo.edu/how/articles.host.html/content/shared/www/eub/here-is-how/Oral-Light-Therapy.detail.html?utm_source=Flipboard&utm_medium=BDM-US-PromotedContent-OralLightTherapy&utm_campaign=FM-Reputation-Fall19&utm_content=OralLightTherapy